Vectura
The Latest
-
Philipp Morris Raises Bid For Respiratory Drugmaker To $1.4 Billion
Philip Morris International increased its bid to acquire respiratory drug company Vectura to outmaneuver Carlye Group's offer. 
Philip Morris International increased its bid to acquire respiratory drug company Vectura to outmaneuver Carlye Group's offer. -
Philip Morris CEO Calls On The UK To Ban Cigarettes Within 10 Years
Philip Morris said it wants to transition to a "health care and wellness company." 
Philip Morris said it wants to transition to a "health care and wellness company."
